Trial Profile

An Open Label, Multicenter Phase I/II Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Relapsed and/or Relapsed/Refractory Multiple Myeloma.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 01 Apr 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs P 276 (Primary)
Indications Multiple myeloma
Focus Adverse reactions; Biomarker
Sponsors Piramal Life Sciences

Most Recent Events

28 Sep 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
09 Jun 2011 Planned End Date changed from 1 Dec 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
22 Jul 2009 New source identified and integrated (Clinical Trials Registry - India, CTRI2008-091-000004).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com